A Phase III, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Effect of AZD0780 on Low-Density Lipoprotein Cholesterol in Patients With Heterozygous Familial Hypercholesterolaemia
Latest Information Update: 06 Jun 2025
At a glance
- Drugs AZD 0780 (Primary)
- Indications Hyperlipoproteinaemia type IIa
- Focus Registrational; Therapeutic Use
- Acronyms AZURE-HeFH
- Sponsors AstraZeneca
Most Recent Events
- 06 Jun 2025 New trial record